Management of chronic myeloid leukemia in chronic phase with autologous stem cell transplantation and alpha-2 interferon: cytogenetic and clinical results.
作者:
主题词
成年人(Adult);血液成分输血(Blood Component Transfusion);输血, 自体(Blood Transfusion, Autologous);骨髓(Bone Marrow);骨髓净化(Bone Marrow Purging);骨髓移植(Bone Marrow Transplantation);综合疗法(Combined Modality Therapy);女(雌)性(Female);造血干细胞移植(Hematopoietic Stem Cell Transplantation);人类(Humans);羟基脲(Hydroxyurea);免疫因子类(Immunologic Factors);干扰素α(Interferon-alpha);意大利(Italy);核型分析(Karyotyping);白血病, 髓系, 慢性, BCR-ABL阳性(Leukemia, Myelogenous, Chronic, BCR-ABL Positive);白血病, 髓样, 慢性期(Leukemia, Myeloid, Chronic-Phase);男(雄)性(Male);中年人(Middle Aged);肿瘤干细胞(Neoplastic Stem Cells);前瞻性研究(Prospective Studies);重组蛋白质类(Recombinant Proteins);缓解诱导(Remission Induction);存活率(Survival Rate);治疗结果(Treatment Outcome)
DOI
10.3109/10428199309047900
PMID
7902746
发布时间
2019-01-16
- 浏览2
Leukemia & lymphoma
281-91页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文